[go: up one dir, main page]

NO861139L - Stabilt gamma-interferonpreparat. - Google Patents

Stabilt gamma-interferonpreparat.

Info

Publication number
NO861139L
NO861139L NO861139A NO861139A NO861139L NO 861139 L NO861139 L NO 861139L NO 861139 A NO861139 A NO 861139A NO 861139 A NO861139 A NO 861139A NO 861139 L NO861139 L NO 861139L
Authority
NO
Norway
Prior art keywords
solution
interferon
preparation
preparation according
gif
Prior art date
Application number
NO861139A
Other languages
English (en)
Norwegian (no)
Inventor
Zachary Yim
Imtiaz Ahmad Chaudry
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO861139L publication Critical patent/NO861139L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO861139A 1985-03-25 1986-03-21 Stabilt gamma-interferonpreparat. NO861139L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71585185A 1985-03-25 1985-03-25
US74093285A 1985-06-03 1985-06-03

Publications (1)

Publication Number Publication Date
NO861139L true NO861139L (no) 1986-09-26

Family

ID=27109430

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861139A NO861139L (no) 1985-03-25 1986-03-21 Stabilt gamma-interferonpreparat.

Country Status (17)

Country Link
EP (1) EP0196203A3 (fr)
KR (1) KR900004799B1 (fr)
CN (1) CN86101878A (fr)
AU (1) AU592552B2 (fr)
DK (1) DK131986A (fr)
ES (1) ES8705761A1 (fr)
FI (1) FI861193A7 (fr)
GR (1) GR860758B (fr)
HU (1) HU200278B (fr)
IL (1) IL78231A (fr)
MA (1) MA20647A1 (fr)
MY (1) MY101973A (fr)
NO (1) NO861139L (fr)
NZ (1) NZ215563A (fr)
OA (1) OA08269A (fr)
PT (1) PT82249B (fr)
TN (1) TNSN86042A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
EP0284249A1 (fr) * 1987-03-13 1988-09-28 Interferon Sciences, Inc. Composition lyophilisée de lymphokine
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
CA2024046A1 (fr) * 1989-09-28 1991-03-29 Alberto Ferro Interferons stabilises
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
TW249202B (fr) * 1993-08-13 1995-06-11 Ciba Gerigy Corp
EP1446142A1 (fr) * 2001-09-27 2004-08-18 Igor Anatolievich Pomytkin Potentialisation des effets therapeutiques des interferons
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras
CN109819650A (zh) * 2017-09-25 2019-05-28 春布里泽·格奥尔基·格奥尔基耶维奇 具有抗病毒和抗细菌活性的热稳定组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4480032A (en) * 1980-11-13 1984-10-30 Yabrov Alexander A Natural mixture of Type I and Type II interferons
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
EP0133767B1 (fr) * 1983-08-04 1991-04-03 The Green Cross Corporation Composition de gamma interféron
EP0168008A3 (fr) * 1984-07-10 1986-12-30 Takeda Chemical Industries, Ltd. Composition stable d'interféron-gamma

Also Published As

Publication number Publication date
IL78231A (en) 1990-07-26
FI861193L (fi) 1986-09-26
TNSN86042A1 (fr) 1990-01-01
ES553232A0 (es) 1987-05-16
DK131986A (da) 1986-09-26
FI861193A0 (fi) 1986-03-21
EP0196203A3 (fr) 1987-09-30
NZ215563A (en) 1989-06-28
KR900004799B1 (ko) 1990-07-06
ES8705761A1 (es) 1987-05-16
PT82249B (en) 1988-01-07
PT82249A (en) 1986-04-01
IL78231A0 (en) 1986-07-31
EP0196203A2 (fr) 1986-10-01
AU5502886A (en) 1986-10-02
DK131986D0 (da) 1986-03-21
HUT40577A (en) 1987-01-28
HU200278B (en) 1990-05-28
CN86101878A (zh) 1986-10-29
GR860758B (en) 1986-07-21
AU592552B2 (en) 1990-01-18
MY101973A (en) 1992-02-29
KR860006982A (ko) 1986-10-06
FI861193A7 (fi) 1986-09-26
OA08269A (fr) 1987-10-30
MA20647A1 (fr) 1986-10-01

Similar Documents

Publication Publication Date Title
US4847079A (en) Biologically stable interferon compositions comprising thimerosal
EP0618807B1 (fr) Formulation pharmaceutique stabilisee comportant une somatotrophine et de l'histidine
JP3898221B2 (ja) トレハロースを含む乾燥血液因子組成物
JP4405666B2 (ja) 安定化テリパラチド溶液剤
JP3031570B2 (ja) 安定化されたゴナドトロピンを含有する調製品
EP0618806B1 (fr) Formulation pharmaceutique stabilisee comprenant une hormone de croissance et de l'asparagine
US6013773A (en) Pharmaceutical preparation containing human growth hormone
US20020077461A1 (en) Pharmaceutical formulation
CA2226523A1 (fr) Formulation pharmaceutique stabilisee comprenant une hormone de croissance pre-traitee avec des ions zinc et facultativement lysine ou calcium
AU738413B2 (en) Human growth hormone-containing aqueous pharmaceutical composition
EP1082133A2 (fr) Formulations pharmaceutiques pour igf/igfbp
NO861139L (no) Stabilt gamma-interferonpreparat.
EP1706150B1 (fr) Formulation liquide stable d'hormones de croissance
JP2002512973A (ja) タンパク質製剤
US8841252B2 (en) Pharmaceutical formulation
JPH11515002A (ja) 副甲状腺ホルモンを含む安定な医薬投与形態
EP0804223B1 (fr) Compositions pharmaceutiques renfermant l'hch
US20060074011A1 (en) Compositions providing for increased IGF-I solubility
US20050163752A1 (en) Human interferon-beta formulations
JP2001524360A (ja) ０．５ｍｌ未満の容量を投与するための凍結乾燥タンパク質組成物を含む１回量注射器
EP0189673A1 (fr) Préparation stable de GRF
JPS61221129A (ja) 安定なγ‐インターフエロン製剤
US9387233B2 (en) Long-term storage of non-glycosylated recombinant human G-CSF
JP2001522814A (ja) 増大されたｉｇｆ−ｉ溶解性を提供する組成物
MXPA06006535A (en) Stable growth hormone liquid formulation